Atrial Size and Anticoagulation in Patients Without Atrial Fibrillation

Clinical Context and Evidence Base

The American Geriatrics Society recommends anticoagulation in patients without atrial fibrillation when the left atrial diameter exceeds 5.5 cm in the setting of rheumatic mitral valve disease, targeting an INR of 2.0-3.0 1, 2
Left atrial diameter >5.5 cm is the established cutoff for considering anticoagulation in patients with rheumatic mitral valve disease who are in normal sinus rhythm 1, 2
Alternative measurement: >5.0 cm (or >50 mm) has also been cited as a threshold in some guidelines 5, 6
The recommendation carries a Grade 2C level of evidence, indicating moderate uncertainty but clinical consensus 3, 1

Anticoagulation may also be considered in patients without AF who have severe mitral stenosis with an enlarged left atrium AND spontaneous echo contrast on echocardiography (Level of Evidence: C) 7
Prior embolic event is a strong indication for anticoagulation regardless of atrial size 1, 2
Dense spontaneous echo contrast in the left atrium on transesophageal echocardiography may also indicate anticoagulation 5, 6

There are no randomized controlled trials demonstrating that oral anticoagulation is beneficial in patients with mitral stenosis who have not had atrial fibrillation or an embolic event 7
The frequency of embolic events in mitral stenosis does not correlate well with the severity of stenosis, cardiac output, or even the size of the left atrium in some studies 7

Aortic valve disease alone: Long-term anticoagulation is NOT recommended regardless of atrial size 4, 2
Mitral valve prolapse or mitral annular calcification: Anticoagulation not indicated based on atrial size alone 4, 2
Non-rheumatic valvular disease: Atrial size is not an indication for anticoagulation in the absence of AF 8

If rheumatic mitral valve disease is present and left atrial diameter is >5.5 cm, consider anticoagulation (INR 2.0-3.0) 1, 2
Prior embolic event is a strong indication for anticoagulation (INR 2.0-3.0) 1, 2

If anticoagulation is initiated based on atrial enlargement, target INR 2.5 (range 2.0-3.0) 1, 2
If recurrent systemic embolism occurs despite adequate anticoagulation, consider intensifying therapy to INR 3.0 (range 2.5-3.5) or adding aspirin 80-100 mg daily 1, 2